TY - JOUR
AU1 - Kalra, Smita K.
AU2 - Singh, Sanjay
AU3 - Grawe, Erin
AU4 - Keshock, Maureen
AU5 - Bentov, Nathalie
AU6 - Richman, Deborah C.
AB - REVIEW ARTICLE * † ‡ § Smita K. Kalra, MD, Sanjay Singh, MD, Erin Grawe, MD, Maureen Keshock, MD, ∥ ¶ Nathalie Bentov, MD, and Deborah C. Richman, MBChB and the perioperative plan. Information is gathered (Int Anesthesiol Clin 2025;63:12–24) through patient-provided history, information from the responsible physician, and device company input. The device company representative is often a necessary part of the perioperative management plan, being present to re- edical device use has grown exponentially in the last program a device as needed. Imaging recommendations Mdecade. Millions of devices are implanted annually are device-specific and involve a multidisciplinary effort to in patients across the globe. These devices are used for a ensure safety. Anesthesia considerations should include variety of clinical indications and have become an area of understanding device interference with a surgical field, considerable interest in newer therapeutic approaches. electromagnetic interference (EMI) by surgical cautery, Patients with these devices undergo procedures unrelated drug and electrolyte interactions, and patient motion ef- to the device, and understanding the function and pro- fects. Aseptic techniques and appropriate prophylactic gramming can help avoid inadvertent patient injury or antibiotics are recommended as per surgical protocol to device malfunction. Due to the vast 
TI - Perioperative Management of Implantable Devices
JF - International Anesthesiology Clinics
DO - 10.1097/aia.0000000000000475
DA - 2025-03-11
UR - https://www.deepdyve.com/lp/wolters-kluwer-health/perioperative-management-of-implantable-devices-QQAgbBzme8
SP - 12
EP - 24
VL - 63
IS - 2
DP - DeepDyve
ER -